Pretransplant pregnancy-associated plasma protein-A as a predictor of chronic allograft nephropathy and posttransplant cardiovascular events

Transplantation

Volumn 80, Issue 10, 2005, Pages 1441-1446

  Lauzurica, Ricardo ^a   Pastor, Cruz ^a   Bayés, Beatriz ^a   Hernández, Jose Maria ^a   Romero, Ramon ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Chronic allograft nephropathy; Chronic rejection; Posttransplant cardiovascular disease; Pretransplant inflammation; Pretransplant PAPP A

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOANALYSIS; CARDIOVASCULAR DISEASE; CHRONIC ALLOGRAFT NEPHROPATHY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE TEST; INFLAMMATION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 29144481593     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000185199.67531.1a     Document Type: Article

References (36)

1. Massy ZA, Guijarro C, Wiederkehr MR, et al. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int 1996; 49: 518.
2. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56: 783.
3. Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307.
4. Dimeny EM: Cardiovascular disease after renal transplantation. Kidney Int 2002; 61: S78.
5. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112.
6. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158.
7. Guijarro C, Massy ZA, Kasiske BL. Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int 1995; 48: S56
8. Kasiske BL: Role of circulating lipid abnormalities in chronic renal allograft rejection. Kidney Int 1999; 56: S28.
9. Lauzurica R, Pastor C, Bayes B, et al. High-sensitivity C-reactive protein as pretransplant marker for acute rejection and cardiovascular morbidity. Transplant Proc 2002; 34: 392.
10. Varagunam M, Finney H, Trevitt R, et al. Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome in Kidney Transplant recipients. Am J Kidney Dis 2004; 43: 502.
11. Fink JC, Onuigbo MA, Blaut SA, et al. Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study. Am J Kidney Dis 2002; 39: 1096.
12. Sezer S, Akcay A, Ozdemir FN, et al. Post transplant C-reactive protein monitoring can predict chronic allograft nephropathy. Clin Transplant 2004; 18: 722.
13. Cueto-Manzano A, Morales-Buenrostro LE, Gonzalez L, et al. Markers of inflammation before and after renal transplantation. Am J Transplant 2004; 4: 1174A.
14. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's Syndrome based on tests performed during the first and second trimesters. N Engl J Med 1999; 341: 461.
15. Bayes-Genis A, Conover CHA, Overgaard MT, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022.
16. Beaudeux JL, Burc L, Imbert-Bismut F, et al. Serum plasma Pregnancy-Associated protein A. A potential marker of echogenic carotid atherosclerotic plaques in asymptomatic Hyperlipidemic subjects at high cardiovascular risk. Arterioscler Thromb Vas Biol 2003; 23: e7.
17. Cosin-Sales J, Christiansen M, Kaminsky P, et al. Pregnancy-Associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (pro MBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004; 109: 1724.
18. Stulc T, Malbohan I, Malik J, et al. Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment. Am Heart J 2003; 146: e21.
19. Fialova L, Kalousova M, Soukupova J, et al. Relationship of pregnancy-associated plasma protein A to renal function and dialysis modalities. Kidney Blood Press Res 2004; 27: 88.
20. Kalousova M, Sulkova S, Fialova L, et al. Glycoxidation and inflammation in chronic haemodyalisis patients. Nephrol Dial Transplant 2003; 18: 2577.
21. Lund J, Qin QP, Ilva T, et al. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003; 108: 1924.
22. Lawrence JB, Oxvig C, Overgaard MT, et al. The insulin-like growth factor (IGF) dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci 1999; 96: 3149.
23. Bayes-Genis A, Conover CA, Schwartz RS. The Insulin-like growth factor Axis. A review of atherosclerosis and reestenosis. Circ Res 2000; 86: 125.
24. Bayes-Genis A, Schwartz RS, Lewis DA, et al. Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 335.
25. Pannen BHJ, Robotham JL. The acute-phase response. New Horiz 1995; 3: 183.
26. Kaysen GA. The Microinflammamatory State in Uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549.
27. Resch ZT, Chen BK, Bale LK, et al. Pregnancy-Associated Plasma Protein, A. Gene expression as a target of inflammatory cytokines. Endocrinology 2004; 145: 1124.
28. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973.
29. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836.
30. Bayes B, Pastor C, Bonal J, et al. Homocysteine, C-reactive protein, lipid peroxidation and mortality in hemodialysis patients. Nephrol Dial Transplant 2003; 18: 106.
31. Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899.
32. Arici M, Walls M. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 2001; 59: 407.
33. Pecoits-Filho R, Barany P, Lindholm B, et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17: 1684.
34. Kalousova M, Horesjsi M, Fialova I, et al. Increased levels of pregnancy-associated plasma protein A associated with mortality in hemodialysis patients: preliminary results. Blood Pur 2004; 22: 298.
35. Nankivell BI, Borrows RI, Fung C, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
36. Pelletier RP, Orosz CG, Cosio FG, Ferguson RM. Risk factors in chronic rejection. Curr Opin Organ Transplant 1999; 4: 28.